Patient has pleural effusion, ascites, or pericardial fluid requiring drainage Note: Patient who had drain removal ?  days prior to planned first dose of study drug and has no sign of worsening is eligible
Uncontrolled pleural effusion, pericardial effusion, or ascites requiring repeated drainage more than once every  days
Uncontrolled pleural effusion, pericardial effusion, or ascites requiring recurrent drainage procedures
Uncontrolled tumor-related pain; pleural effusion, pericardial effusion, or ascites requiring recurrent drainage procedures; or, hypercalcemia or symptomatic hypercalcemia requiring continued use of bisphosphonate therapy or denosumab.
Uncontrolled pleural effusion, pericardial effusion, or ascites requiring repeated drainage more than once every  days
Uncontrolled pleural effusion, pericardial effusion, or ascites requiring recurrent drainage procedures (once monthly or more frequently) (patients with indwelling catheters such as PleurX are allowed)
Uncontrolled pleural effusion, pericardial effusion, or ascites requiring recurrent drainage procedures (once monthly or more frequently)
Ascites, pleural effusion, or pericardial fluid requiring drainage in the last  weeks prior to registration
Grade  or higher ascites, pleural, or pericardial effusion within  weeks of study enrollment or any history of recurrent grade  or higher effusions requiring ongoing drainage.
Uncontrolled pleural or pericardial effusion or ascites that would require recurrent drainage
Uncontrolled pleural effusion, pericardial effusion, or ascites requiring recurrent drainage procedures (once monthly or more frequently)\r\n* Subjects with indwelling drainage catheters are allowed
Patients with large and recurrent pleural or peritoneal effusions requiring frequent drainage (e.g. weekly); patients with any amount of clinically significant pericardial effusion
Uncontrolled pleural or pericardial effusion or ascites that would require recurrent drainage
Uncontrollable pleural effusion, pericardial effusion, or ascites requiring frequent drainage
Uncontrolled pleural effusion, pericardial effusion, or ascites requiring recurrent drainage procedures >/= time per month
Patients with large and recurrent pleural or peritoneal effusions requiring frequent drainage (e.g. weekly); patients with any amount of clinically significant pericardial effusion
Has significant ascites or pleural effusion requiring drainage for symptom relief
Uncontrolled effusion, pericardial effusion, or ascites requiring recurrent drainage procedures (once monthly or more frequently)
Ascites, pleural effusion or pericardial fluid requiring drainage in the last  weeks
Patients with large and recurrent pleural or peritoneal effusions requiring frequent drainage (e.g. weekly); patients with any amount of clinically significant pericardial effusion
Uncontrolled pleural effusion, pericardial effusion, or ascites requiring drainage at least once monthly.
Uncontrolled pleural effusion, pericardial effusion, or ascites requiring recurrent drainage procedures (once monthly or more frequently); participants with indwelling catheters are eligible
Subjects with ascites or pleural effusion requiring drainage within the last  days.
Uncontrolled pleural, pericardial effusions, or ascites requiring recurrent drainage procedures
Uncontrolled pleural effusion, pericardial effusion, or ascites (indwelling drainage catheters allowed)
Uncontrolled pleural effusion, pericardial effusion, or ascites requiring recurrent drainage procedures (once monthly or more frequently)
Uncontrolled tumor-related pain or uncontrolled pleural effusion, pericardial effusion, or ascites requiring recurrent (once monthly or more frequently) drainage procedures
Uncontrolled pleural effusion, pericardial effusion, or ascites requiring recurrent drainage procedures
Patients with a pleural effusion requiring continuous drainage
Symptomatic pleural effusion (> CTCAE Grade  dyspnea) that is not amenable to drainage
Patients require regular ascites/pleural effusion drainage
Patient with pleural effusion, ascites, or pericardial fluid requiring drainage.
Patient has pleural effusion, ascites, or pericardial fluid requiring drainage. Note: Patient who had drain removal ?  days prior to planned first dose of study drug and has no sign of worsening is eligible.
Pleural effusion requiring repetitive drainage, i.e., an indwelling catheter or  thoracenteses with  weeks of the first dose of mogamulizumab;
Pleural effusion, pericardial fluid, or ascites requiring drainage every other week or more frequently
Uncontrolled pleural effusion, pericardial effusion, or ascites requiring recurrent drainage procedures
Uncontrolled pleural effusion, pericardial effusion, or ascites requiring recurrent drainage procedures
No effusion or ascites >  L prior to drainage
Uncontrolled pleural effusion, pericardial effusion or ascites requiring recurrent drainage procedures
Uncontrolled pleural effusion, pericardial effusion, or ascites requiring recurrent drainage procedures (once monthly or more frequently)